Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis.
Cannabis legalization is expanding, but there are no established methods for detecting cannabis impairment. Characterize the acute impairing effects of oral and vaporized cannabis using various performance tests. Participants ( Low oralvaporized doses did not impair cognitivepsychomotor performance relative to placebo but produced positive subjective effects. High oralvaporized doses impaired cognitivepsychomotor performance and increased positive and negative subjective effects. The DRUID Standard approaches for identifying impairment due to cannabis exposure (i.e. blood THC and field sobriety tests) have severe limitations. There is a need to identify novel biomarkers of cannabis exposure andor behavioral tests like the DRUID